Lamivudine 150mg + Zodovudine 300mg + Nevirapine 200mg Tablets

Get a Price/Quote

MOQ : 5000 Boxes

Lamivudine 150mg + Zodovudine 300mg + Nevirapine 200mg Tablets Specification

Pacakaging (Quantity Per Box)
10 x 10 tablets

Expiration Date
24 to 36 months from date of manufacture

Assay
Not less than 98% and not more than 102% of labeled amount

Origin of Medicine
India

Medicine Type
Allopathic

Storage
Store below 30C, protect from light and moisture

Dosage
Lamivudine 150mg, Zidovudine 300mg, Nevirapine 200mg

Molecular Formula
Lamivudine (C8H11N3O3S), Zidovudine (C10H13N5O4), Nevirapine (C15H14N4O)

Usage
HIV-1 infection treatment

Grade
Pharmaceutical Grade

Appearance
Film coated tablet

Indication
Indicated as part of combination antiretroviral therapy for the treatment of HIV infection

Dosage Form
Tablet

CAS No
872365-14-5 (Lamivudine), 30516-87-1 (Zidovudine), 129618-40-2 (Nevirapine)

Salt Composition
Lamivudine + Zidovudine + Nevirapine

Lamivudine 150mg + Zodovudine 300mg + Nevirapine 200mg Tablets Trade Information

Minimum Order Quantity
5000 Boxes

FOB Port
M

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Supply Ability
100000 Boxes Per Month

Delivery Time
45 - 60 Days

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
AS PER BUYERS REQUIREMENT.

Main Export Market(s)
South America, Middle East, Eastern Europe, Australia, Central America, Africa, Western Europe, Asia, North America

Main Domestic Market
All India

Certifications
WHO GMP,ISO,FSSAI

About Lamivudine 150mg + Zodovudine 300mg + Nevirapine 200mg Tablets

Redeem instant savings on Lamivudine 150mg + Zidovudine 300mg + Nevirapine 200mg Tablets, a superior antiretroviral solution designed for the effective management of HIV-1 infection. With spectacular pharmaceutical grade quality and marvelous regulatory compliance (USP/BP/IP), this combination guarantees not less than 98% and not more than 102% assay. Limited stock available! These film-coated tablets offer rapid disintegration (less than 30 minutes) and come in secure blister packs or bottles. The product provides a shelf life of up to 36 months, maintaining stability under 30C. Only available by prescription from reputable Indian manufacturers and wholesalers. Act swiftly to secure this trusted, high-quality therapeutic option.

Advantageous Approach to HIV-1 Management

Lamivudine 150mg + Zidovudine 300mg + Nevirapine 200mg Tablets are used as a crucial component in combination antiretroviral therapy for HIV-1 infection. Designed for oral administration, these tablets offer plant-verified pharmaceutical grade quality. The advantage of a fixed-dose combination simplifies treatment regimens while enhancing patient adherence. Its superior shelf life and regulatory compliance make it a go-to option for healthcare providers seeking efficacy and convenience in managing HIV-infected patients.

Sample Availability and Global Export Opportunities

Samples of the Lamivudine 150mg + Zidovudine 300mg + Nevirapine 200mg Tablets are available for evaluation. With quick dispatch and a streamlined supply process, we cater to major export markets worldwide, including Asia, Africa, and Latin America. Each batch is supported by relevant certifications and regulatory documentation. Get in touch for a prompt quotation and to experience our efficient packaging, secure delivery, and robust product compliance tailored for distributors, exporters, and wholesalers.

FAQs of Lamivudine 150mg + Zodovudine 300mg + Nevirapine 200mg Tablets:

Q: How should Lamivudine 150mg + Zidovudine 300mg + Nevirapine 200mg Tablets be taken?

A: These tablets should be taken orally as prescribed by your healthcare provider, usually once or twice daily with or without food, as part of a combination antiretroviral therapy for HIV infection.

Q: What benefits do these tablets offer for HIV treatment?

A: This fixed-dose combination offers superior convenience by reducing pill burden and improving adherence, while maintaining consistent antiretroviral effects to help control HIV-1 infection.

Q: When should I consider starting this medication?

A: Start Lamivudine + Zidovudine + Nevirapine tablets only under the direct guidance of a qualified physician when a combination antiretroviral therapy is deemed necessary for HIV management.

Q: Where is this product manufactured and supplied from?

A: The tablets are manufactured in India and supplied globally by certified dealers, exporters, and wholesalers with a strong record of regulatory compliance.

Q: What is the process to place an order or request a sample?

A: For ordering or sample requests, contact our sales team with your requirements. We provide quick dispatch, competitive quotations, and thoroughly support every batch with relevant documentation and certification.

Q: Are there any side effects to be aware of?

A: Possible side effects include nausea, headache, fatigue, and rash. Consult your healthcare provider for a complete assessment of potential risks and individualized monitoring.

Tell us about your requirement